Literature DB >> 21910238

Partial agenesis of the corpus callosum, hippocampal atrophy, and stable intellectual disability associated with Roifman syndrome.

Helen R Fairchild1, Graeme Fairchild, Kevin M Tierney, Deborah L McCartney, Justin J Cross, Petrus J de Vries.   

Abstract

In 2006, we reported the cognitive and behavioral phenotype of the seventh case of Roifman syndrome (OMIM 300258). Aged 11 years 6 months, the patient displayed significant intellectual disability with proportionate impairments in attentional-executive, memory, and visuo-spatial abilities despite appearing socially "able." This discrepancy may be explained by good social-emotional skills masking his intellectual disability, by decline in cognitive abilities over time, or by unusual neuroradiological abnormalities not previously examined in Roifman syndrome. Here, we present results from a structural MRI scan, neurocognitive evaluations repeated 2 and 5 years post-baseline and assessments of face and emotional processing. The MRI revealed partial agenesis of the corpus callosum, bilateral hypoplastic hippocampi but bilaterally intact amygdala. No evidence was found for decline in the patient's neurocognitive profile. Emotional processing data indicated an age-appropriate pattern of reactivity to emotional stimuli and preserved facial identity recognition abilities, but impairments in recognition of negative facial expressions. The results confirmed a stable pattern of intellectual disability, and indicated that Roifman syndrome may be associated with major structural neuro-anatomical abnormalities. We suggest that the relative strengths in emotion and face processing are consistent with the patient's apparently able social behavior, and with intact amygdalar function.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21910238     DOI: 10.1002/ajmg.a.34215

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  A homozygous mutation in the stem II domain of RNU4ATAC causes typical Roifman syndrome.

Authors:  Yael Dinur Schejter; Adi Ovadia; Roumiana Alexandrova; Bhooma Thiruvahindrapuram; Sergio L Pereira; David E Manson; Ajoy Vincent; Daniele Merico; Chaim M Roifman
Journal:  NPJ Genom Med       Date:  2017-07-10       Impact factor: 8.617

2.  Compound heterozygous mutations in the noncoding RNU4ATAC cause Roifman Syndrome by disrupting minor intron splicing.

Authors:  Daniele Merico; Maian Roifman; Ulrich Braunschweig; Ryan K C Yuen; Roumiana Alexandrova; Andrea Bates; Brenda Reid; Thomas Nalpathamkalam; Zhuozhi Wang; Bhooma Thiruvahindrapuram; Paul Gray; Alyson Kakakios; Jane Peake; Stephanie Hogarth; David Manson; Raymond Buncic; Sergio L Pereira; Jo-Anne Herbrick; Benjamin J Blencowe; Chaim M Roifman; Stephen W Scherer
Journal:  Nat Commun       Date:  2015-11-02       Impact factor: 14.919

3.  Extending the critical regions for mutations in the non-coding gene RNU4ATAC in another patient with Roifman Syndrome.

Authors:  Ariane Hallermayr; Janine Graf; Udo Koehler; Andreas Laner; Brigitte Schönfeld; Anna Benet-Pagès; Elke Holinski-Feder
Journal:  Clin Case Rep       Date:  2018-10-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.